Delivery Order SPE2DB24D2010-SPE2DB25FAAVJ
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $2,360.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on July 25, 2025, with a completion date of July 28, 2025. This non-competitive delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the Department of Defense medical supply chain. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $54,083.66 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 12, 2025. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $7,755.60 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pens on August 7, 2025, with completion targeted for August 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $3,812.90 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on April 22, 2025, with completion scheduled for April 23, 2025. This competitively awarded, firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under a child delivery order structure, leveraging the company's broader contracting...
- The Defense Logistics Agency awarded a delivery order valued at $4,760.40 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pens on September 18, 2025, with completion scheduled for September 19, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive procurement for pharmaceutical supplies to support federal medical needs. The award was made to AmerisourceBergen's corporate office, with performance occurring at the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,943.82 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens with a completion date of October 17, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp is a major healthcare solutions provider and one of the federal government's critical pharmaceutical vendors,...
- The Defense Logistics Agency awarded a $3,677.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for supply of Mounjaro 15 mg/0.5 mL pens on September 3, 2025, with completion by September 4, 2025. This non-set-aside competitively awarded contract represents a single delivery order fulfillment from AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $2,955.49 firm fixed price delivery order to AmerisourceBergen Drug Corp for supply of Mounjaro 7.5 mg/0.5 mL pens on July 15, 2025, with completion targeted for July 16, 2025. This non-set-aside delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens valued at $1,904.63 with a completion date of June 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAVJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,392.79 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pens on August 15, 2025, with completion expected by August 18, 2025. This firm fixed price, non-set-aside delivery order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026 that serves as a comprehensive pharmaceutical support mechanism for global military healthcare programs. The company maintains an extensive portfolio of competitively awarded contracts with the Defense Logistics Agency covering a wide range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. Through this contract structure, AmerisourceBergen supplies critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/15/25 |